You are here

  • Home
  • Archive
  • Volume 35, Issue 8
  • Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial

Article info

Article menu
Download PDFPDF
Original article
Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial

Authors

  • Dawn Dalen Emergency Medicine, Kelowna General Hospital, Kelowna, British Columbia, Canada Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Amy Fry Department of Pharmacy, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada PubMed articlesGoogle scholar articles
  • Samuel G Campbell Department of Emergency Medicine, Dalhousie University, Halifax, Nova Scotia, Canada Department of Emergency Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada PubMed articlesGoogle scholar articles
  • Jeffrey Eppler Department of Emergency Medicine, Kelowna General Hospital, Kelowna, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Peter J Zed Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Peter J Zed, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada; peter.zed{at}ubc.ca
View Full Text

Citation

Dalen D, Fry A, Campbell SG, et al
Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial
Emergency Medicine Journal 2018;35:492-498.

Publication history

  • Received December 22, 2017
  • Revised May 1, 2018
  • Accepted May 10, 2018
  • First published June 18, 2018.
Online issue publication 
July 20, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.